Table of Contents Global H3N2 Infection Treatment Professional Survey Report Report 2022, Forecast to 2027 1 Market Study Overview 1.1 Study Objectives 1.2 H3N2 Infection Treatment Introduce 1.3 Combined with the Analysis of Macroeconomic Indicators 1.4 Brief Description of Research Methods 1.5 Market Breakdown and Data Triangulation 2 Global Trend Summary 2.1 H3N2 Infection Treatment Segment by Type 2.1.1 APP-309 2.1.2 Aspidasept 2.1.3 C-05 2.1.4 CR-8020 2.1.5 Others 2.2 Market Analysis by Application 2.2.1 Clinic 2.2.2 Hospital 2.2.3 Others 2.3 Global H3N2 Infection Treatment Market Comparison by Regions (2017-2027) 2.3.1 Global H3N2 Infection Treatment Market Size (2017-2027) 2.3.2 North America H3N2 Infection Treatment Status and Prospect (2017-2027) 2.3.3 Europe H3N2 Infection Treatment Status and Prospect (2017-2027) 2.3.4 Asia-pacific H3N2 Infection Treatment Status and Prospect (2017-2027) 2.3.5 South America H3N2 Infection Treatment Status and Prospect (2017-2027) 2.3.6 Middle East & Africa H3N2 Infection Treatment Status and Prospect (2017-2027) 2.4 Basic Product Information 2.4.1 Basic Product Information & Technology Development History 2.4.2 Product Manufacturing Process 2.4.3 Interview with Major Market Participants 2.4.4 High-end Market Analysis and Forecast 2.5 Coronavirus Disease 2019 (Covid-19): H3N2 Infection Treatment Industry Impact 2.5.1 H3N2 Infection Treatment Business Impact Assessment - Covid-19 2.5.2 Market Trends and H3N2 Infection Treatment Potential Opportunities in the COVID-19 Landscape 2.5.3 Measures / Proposal against Covid-19 3 Competition by Manufacturer 3.1 Global H3N2 Infection Treatment Sales and Market Share by Manufacturer (2017-2022) 3.2 Global H3N2 Infection Treatment Revenue and Market Share by Manufacturer (2017-2022) 3.3 Global H3N2 Infection Treatment Industry Concentration Ratio (CR5 and HHI) 3.4 Top 5 H3N2 Infection Treatment Manufacturer Market Share 3.5 Top 10 H3N2 Infection Treatment Manufacturer Market Share 3.6 Date of Key Manufacturers Enter into H3N2 Infection Treatment Market 3.7 Key Manufacturers H3N2 Infection Treatment Product Offered 3.8 Mergers & Acquisitions Planning 4 Analysis of H3N2 Infection Treatment Industry Key Manufacturers 4.1 AIMM Therapeutics B.V. 4.1.1 Company Details 4.1.2 AIMM Therapeutics B.V. H3N2 Infection Treatment Product Introduction, Application and Specification 4.1.3 AIMM Therapeutics B.V. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.1.4 Main Business Overview 4.1.5 AIMM Therapeutics B.V. News 4.2 Johnson & Johnson 4.2.1 Company Details 4.2.2 Johnson & Johnson H3N2 Infection Treatment Product Introduction, Application and Specification 4.2.3 Johnson & Johnson H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.2.4 Main Business Overview 4.2.5 Johnson & Johnson News 4.3 CSL Limited 4.3.1 Company Details 4.3.2 CSL Limited H3N2 Infection Treatment Product Introduction, Application and Specification 4.3.3 CSL Limited H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.3.4 Main Business Overview 4.3.5 CSL Limited News 4.4 Aphios Corporation 4.4.1 Company Details 4.4.2 Aphios Corporation H3N2 Infection Treatment Product Introduction, Application and Specification 4.4.3 Aphios Corporation H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.4.4 Main Business Overview 4.4.5 Aphios Corporation News 4.5 Inovio Pharmaceuticals, Inc. 4.5.1 Company Details 4.5.2 Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.5.3 Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.5.4 Main Business Overview 4.5.5 Inovio Pharmaceuticals, Inc. News 4.6 Crucell N.V. 4.6.1 Company Details 4.6.2 Crucell N.V. H3N2 Infection Treatment Product Introduction, Application and Specification 4.6.3 Crucell N.V. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.6.4 Main Business Overview 4.6.5 Crucell N.V. News 4.7 MedImmune, LLC 4.7.1 Company Details 4.7.2 MedImmune, LLC H3N2 Infection Treatment Product Introduction, Application and Specification 4.7.3 MedImmune, LLC H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.7.4 Main Business Overview 4.7.5 MedImmune, LLC News 4.8 ILiAD Biotechnologies, LLC 4.8.1 Company Details 4.8.2 ILiAD Biotechnologies, LLC H3N2 Infection Treatment Product Introduction, Application and Specification 4.8.3 ILiAD Biotechnologies, LLC H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.8.4 Main Business Overview 4.8.5 ILiAD Biotechnologies, LLC News 4.9 Glide Pharmaceutical Technologies Limited 4.9.1 Company Details 4.9.2 Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Product Introduction, Application and Specification 4.9.3 Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.9.4 Main Business Overview 4.9.5 Glide Pharmaceutical Technologies Limited News 4.10 Medicago Inc. 4.10.1 Company Details 4.10.2 Medicago Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.10.3 Medicago Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.10.4 Main Business Overview 4.10.5 Medicago Inc. News 4.11 Sarepta Therapeutics, Inc. 4.11.1 Company Details 4.11.2 Sarepta Therapeutics, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.11.3 Sarepta Therapeutics, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.11.4 Main Business Overview 4.11.5 Sarepta Therapeutics, Inc. News 4.12 Zydus Cadila Healthcare Limited 4.12.1 Company Details 4.12.2 Zydus Cadila Healthcare Limited H3N2 Infection Treatment Product Introduction, Application and Specification 4.12.3 Zydus Cadila Healthcare Limited H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.12.4 Main Business Overview 4.12.5 Zydus Cadila Healthcare Limited News 4.13 Mucosis B.V. 4.13.1 Company Details 4.13.2 Mucosis B.V. H3N2 Infection Treatment Product Introduction, Application and Specification 4.13.3 Mucosis B.V. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.13.4 Main Business Overview 4.13.5 Mucosis B.V. News 4.14 Takeda Pharmaceutical Company Limited 4.14.1 Company Details 4.14.2 Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Product Introduction, Application and Specification 4.14.3 Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.14.4 Main Business Overview 4.14.5 Takeda Pharmaceutical Company Limited News 4.15 OPKO Health, Inc. 4.15.1 Company Details 4.15.2 OPKO Health, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.15.3 OPKO Health, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.15.4 Main Business Overview 4.15.5 OPKO Health, Inc. News 4.16 NanoViricides, Inc. 4.16.1 Company Details 4.16.2 NanoViricides, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.16.3 NanoViricides, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.16.4 Main Business Overview 4.16.5 NanoViricides, Inc. News 4.17 Visterra, Inc. 4.17.1 Company Details 4.17.2 Visterra, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.17.3 Visterra, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.17.4 Main Business Overview 4.17.5 Visterra, Inc. News 4.18 Novavax, Inc. 4.18.1 Company Details 4.18.2 Novavax, Inc. H3N2 Infection Treatment Product Introduction, Application and Specification 4.18.3 Novavax, Inc. H3N2 Infection Treatment Sales, Price, Cost, Gross Margin, and Revenue (2017-2022) 4.18.4 Main Business Overview 4.18.5 Novavax, Inc. News 5 Global H3N2 Infection Treatment Sales Categorized by Regions 5.1 Global H3N2 Infection Treatment Revenue, Sales and Market Share by Regions 5.1.1 Global H3N2 Infection Treatment Sales and Market Share by Regions (2017-2022) 5.1.2 Global H3N2 Infection Treatment Revenue and Market Share by Regions (2017-2022) 5.2 North America H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 5.3 Europe H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 5.4 Asia-pacific H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 5.5 South America H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 5.6 Middle East & Africa H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 6 North America H3N2 Infection Treatment Market Size Categorized by Countries 6.1 North America H3N2 Infection Treatment Sales, Revenue and Market Share by Countries 6.1.1 North America H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) 6.1.2 North America H3N2 Infection Treatment Revenue by Countries (2017-2022) 6.1.3 United States H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 6.1.4 Canada H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 6.1.5 Mexico H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 6.2 North America H3N2 Infection Treatment Revenue (Value) by Manufacturers 6.3 North America H3N2 Infection Treatment Sales and Market Share by Type (2017-2022) 6.4 North America H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 7 Europe H3N2 Infection Treatment Market Size Categorized by Countries 7.1 Europe H3N2 Infection Treatment Sales, Revenue and Market Share by Countries 7.1.1 Europe H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) 7.1.2 Europe H3N2 Infection Treatment Revenue by Countries (2017-2022) 7.1.3 Germany H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.1.4 UK H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.1.5 France H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.1.6 Russia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.1.7 Italy H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.1.8 Spain H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 7.2 Europe H3N2 Infection Treatment Revenue (Value) by Manufacturers 7.3 Europe H3N2 Infection Treatment Sales and Market Share by Type (2017-2022) 7.4 Europe H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 8 Asia-Pacific H3N2 Infection Treatment Market Size Categorized by Countries 8.1 Asia-pacific H3N2 Infection Treatment Sales, Revenue and Market Share by Countries 8.1.1 Asia-pacific H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) 8.1.2 Asia-pacific H3N2 Infection Treatment Revenue by Countries (2017-2022) 8.1.3 China H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.1.4 South Korea H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.1.5 Japan H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.1.6 Australia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.1.7 India H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.1.8 Southeast Asia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 8.2 Asia-pacific H3N2 Infection Treatment Revenue (Value) by Manufacturers 8.3 Asia-pacific H3N2 Infection Treatment Sales and Market Share by Type (2017-2022) 8.4 Asia-pacific H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 9 South America H3N2 Infection Treatment Market Size Categorized by Countries 9.1 South America H3N2 Infection Treatment Sales, Revenue and Market Share by Countries 9.1.1 South America H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) 9.1.2 South America H3N2 Infection Treatment Revenue by Countries (2017-2022) 9.1.3 Brazil H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 9.2 South America H3N2 Infection Treatment Sales and Market Share by Type (2017-2022) 9.3 South America H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 10 Middle East and Africa H3N2 Infection Treatment Market Size Categorized by Countries 10.1 Middle East and Africa H3N2 Infection Treatment Sales, Revenue and Market Share by Countries 10.1.1 Middle East and Africa H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) 10.1.2 Middle East and Africa H3N2 Infection Treatment Revenue by Countries (2017-2022) 10.1.3 GCC Countries H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 10.1.4 Turkey H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 10.1.5 Egypt H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 10.1.6 South America H3N2 Infection Treatment Sales and Growth Rate (2017-2022) 10.2 Middle East and Africa H3N2 Infection Treatment Sales and Market Share by Type 10.3 Middle East and Africa H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 11 Global H3N2 Infection Treatment Market Segment by Type 11.1 Global H3N2 Infection Treatment Revenue, Sales and Market Share by Type (2017-2022) 11.1.1 Global H3N2 Infection Treatment Sales and Market Share by Type (2017-2022) 11.1.2 Global H3N2 Infection Treatment Revenue and Market Share by Type (2017-2022) 11.2 APP-309 Sales Growth Rate and Price 11.2.1 Global APP-309 Sales Growth Rate (2017-2022) 11.2.2 Global APP-309 Price (2017-2022) 11.3 Aspidasept Sales Growth Rate and Price 11.3.1 Global Aspidasept Sales Growth Rate (2017-2022) 11.3.2 Global Aspidasept Price (2017-2022) 11.4 C-05 Sales Growth Rate and Price 11.4.1 Global C-05 Sales Growth Rate (2017-2022) 11.4.2 Global C-05 Price (2017-2022) 11.5.1 Global CR-8020 Sales Growth Rate (2017-2022) 11.5.2 Global CR-8020 Price (2017-2022) 11.6 Others Sales Growth Rate and Price 11.6.1 Global Others Sales Growth Rate (2017-2022) 11.6.2 Global Others Price (2017-2022) 12 Global H3N2 Infection Treatment Market Segment by Application 12.1 Global H3N2 Infection Treatment Sales Market Share by Application (2017-2022) 12.2 Clinic Sales Growth Rate (2017-2022) 12.3 Hospital Sales Growth Rate (2017-2022) 12.4 Others Sales Growth Rate (2017-2022) 13 Global H3N2 Infection Treatment Market Forecast 13.1 Global H3N2 Infection Treatment Revenue, Sales and Growth Rate (2022-2027) 13.2 H3N2 Infection Treatment Market Forecast by Regions (2022-2027) 13.2.1 North America H3N2 Infection Treatment Market Forecast (2022-2027) 13.2.2 Europe H3N2 Infection Treatment Market Forecast (2022-2027) 13.2.3 Asia-Pacific H3N2 Infection Treatment Market Forecast (2022-2027) 13.2.4 South America H3N2 Infection Treatment Market Forecast (2022-2027) 13.2.5 Middle East & Africa H3N2 Infection Treatment Market Forecast (2022-2027) 13.3 H3N2 Infection Treatment Market Forecast by Type (2022-2027) 13.3.1 Global H3N2 Infection Treatment Sales Forecast by Type (2022-2027) 13.3.2 Global H3N2 Infection Treatment Market Share Forecast by Type (2022-2027) 13.4 H3N2 Infection Treatment Market Forecast by Application (2022-2027) 13.4.1 Global H3N2 Infection Treatment Sales Forecast by Application (2022-2027) 13.4.2 Global H3N2 Infection Treatment Market Share Forecast by Application (2022-2027) 14 Market Analysis 14.1.1 Market overview 14.1.2 Market Opportunities 14.1.3 Market Risk 14.1.4 Market Driving Force 14.1.5 Porter's Five Forces Analysis 14.1.6 SWOT Analysis 15 H3N2 Infection Treatment Industry Related Market Analysis 15.1 Upstream Analysis 15.1.1 Macro Analysis of Upstream Markets 15.1.2 Key Players in Upstream Markets 15.1.3 Upstream Market Trend Analysis 15.1.4 H3N2 Infection Treatment Manufacturing Cost Analysis 15.2 Downstream Market Analysis 15.2.1 Macro Analysis of Down Markets 15.2.2 Key Players in Down Markets 15.2.3 Downstream Market Trend Analysis 15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures Figure Product Picture H3N2 Infection Treatment Figure Market Concentration Ratio and Market Maturity Analysis of H3N2 Infection Treatment Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Part of Our External Database Figure Key Executives Interviewed Table Global H3N2 Infection Treatment Market Size by Type Figure Global Market Share of H3N2 Infection Treatment by Type in 2021 Figure APP-309 Picture Figure Aspidasept Picture Figure C-05 Picture Figure CR-8020 Picture Figure Others Picture Table Global H3N2 Infection Treatment Market Size (Volume) by Application Figure Clinic Picture Figure Hospital Picture Figure Others Picture Table Global H3N2 Infection Treatment Comparison by Regions (M USD) 2017-2027 Figure Global H3N2 Infection Treatment Market Size (Million US$) (2017-2027) Figure North America H3N2 Infection Treatment Revenue (Million US$) Growth Rate (2017-2027) Figure Europe H3N2 Infection Treatment Revenue (Million US$) Growth Rate (2017-2027) Figure Asia-pacific H3N2 Infection Treatment Revenue (Million US$) Growth Rate (2017-2027) Figure South America H3N2 Infection Treatment Revenue (Million US$) Growth Rate (2017-2027) Figure Middle East & Africa H3N2 Infection Treatment Revenue (Million US$) Growth Rate (2017-2027) Table Business Impact Assessment - Covid-19 Table Market Trends and H3N2 Infection Treatment Potential Opportunities in the COVID-19 Landscape Table Measures / Proposal against Covid-19 Table Global H3N2 Infection Treatment Sales by Manufacturer (2017-2022) Figure Global H3N2 Infection Treatment Sales Market Share by Manufacturer in 2021 Table Global H3N2 Infection Treatment Revenue by Manufacturer (2017-2022) Figure Global H3N2 Infection Treatment Revenue Market Share by Manufacturer in 2021 Table Global H3N2 Infection Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 H3N2 Infection Treatment Manufacturer (Revenue) Market Share in 2021 Figure Top 10 H3N2 Infection Treatment Manufacturer (Revenue) Market Share in 2021 Table Date of Key Manufacturers Enter into H3N2 Infection Treatment Market Table Key Manufacturers H3N2 Infection Treatment Product Type Table Mergers & Acquisitions Planning Table AIMM Therapeutics B.V. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of AIMM Therapeutics B.V. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AIMM Therapeutics B.V. 2017-2022 Table AIMM Therapeutics B.V. Main Business Table AIMM Therapeutics B.V. Recent Development Table Johnson & Johnson Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Johnson & Johnson Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2022 Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table CSL Limited Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of CSL Limited Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CSL Limited 2017-2022 Table CSL Limited Main Business Table CSL Limited Recent Development Table Aphios Corporation Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Aphios Corporation Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aphios Corporation 2017-2022 Table Aphios Corporation Main Business Table Aphios Corporation Recent Development Table Inovio Pharmaceuticals, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Inovio Pharmaceuticals, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Inovio Pharmaceuticals, Inc. 2017-2022 Table Inovio Pharmaceuticals, Inc. Main Business Table Inovio Pharmaceuticals, Inc. Recent Development Table Crucell N.V. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Crucell N.V. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Crucell N.V. 2017-2022 Table Crucell N.V. Main Business Table Crucell N.V. Recent Development Table MedImmune, LLC Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of MedImmune, LLC Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of MedImmune, LLC 2017-2022 Table MedImmune, LLC Main Business Table MedImmune, LLC Recent Development Table ILiAD Biotechnologies, LLC Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of ILiAD Biotechnologies, LLC Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of ILiAD Biotechnologies, LLC 2017-2022 Table ILiAD Biotechnologies, LLC Main Business Table ILiAD Biotechnologies, LLC Recent Development Table Glide Pharmaceutical Technologies Limited Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Glide Pharmaceutical Technologies Limited Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Glide Pharmaceutical Technologies Limited 2017-2022 Table Glide Pharmaceutical Technologies Limited Main Business Table Glide Pharmaceutical Technologies Limited Recent Development Table Medicago Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Medicago Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Medicago Inc. 2017-2022 Table Medicago Inc. Main Business Table Medicago Inc. Recent Development Table Sarepta Therapeutics, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Sarepta Therapeutics, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sarepta Therapeutics, Inc. 2017-2022 Table Sarepta Therapeutics, Inc. Main Business Table Sarepta Therapeutics, Inc. Recent Development Table Zydus Cadila Healthcare Limited Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Zydus Cadila Healthcare Limited Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Zydus Cadila Healthcare Limited 2017-2022 Table Zydus Cadila Healthcare Limited Main Business Table Zydus Cadila Healthcare Limited Recent Development Table Mucosis B.V. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Mucosis B.V. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Mucosis B.V. 2017-2022 Table Mucosis B.V. Main Business Table Mucosis B.V. Recent Development Table Takeda Pharmaceutical Company Limited Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Takeda Pharmaceutical Company Limited Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Takeda Pharmaceutical Company Limited 2017-2022 Table Takeda Pharmaceutical Company Limited Main Business Table Takeda Pharmaceutical Company Limited Recent Development Table OPKO Health, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of OPKO Health, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of OPKO Health, Inc. 2017-2022 Table OPKO Health, Inc. Main Business Table OPKO Health, Inc. Recent Development Table NanoViricides, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of NanoViricides, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of NanoViricides, Inc. 2017-2022 Table NanoViricides, Inc. Main Business Table NanoViricides, Inc. Recent Development Table Visterra, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Visterra, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Visterra, Inc. 2017-2022 Table Visterra, Inc. Main Business Table Visterra, Inc. Recent Development Table Novavax, Inc. Company Profile Table H3N2 Infection Treatment Product Introduction, Application and Specification of Novavax, Inc. Table H3N2 Infection Treatment Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novavax, Inc. 2017-2022 Table Novavax, Inc. Main Business Table Novavax, Inc. Recent Development Figure Global H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Global H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table Global H3N2 Infection Treatment Sales by Regions (2017-2022) Figure Global H3N2 Infection Treatment Sales Market Share by Regions in 2021 Table Global H3N2 Infection Treatment Revenue by Regions (2017-2022) Figure Global H3N2 Infection Treatment Revenue Market Share by Regions in 2021 Figure North America H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Europe H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Asia-pacific H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure South America H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Middle East & Africa H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure North America H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table North America H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) Table North America H3N2 Infection Treatment Sales Market Share by Countries (2017-2022) Figure North America H3N2 Infection Treatment Sales Market Share by Countries in 2021 Table North America H3N2 Infection Treatment Revenue by Countries (2017-2022) Table North America H3N2 Infection Treatment Revenue Market Share by Countries (2017-2022) Figure North America H3N2 Infection Treatment Revenue Market Share by Countries in 2021 Figure United States H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Canada H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Mexico H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Table North America H3N2 Infection Treatment Revenue by Manufacturer (2021) Figure North America H3N2 Infection Treatment Revenue Market Share by Manufacturer in 2021 Table North America H3N2 Infection Treatment Sales by Type (2017-2022) Table North America H3N2 Infection Treatment Sales Share by Type (2017-2022) Table North America H3N2 Infection Treatment Sales by Application (2017-2022) Table North America H3N2 Infection Treatment Sales Share by Application (2017-2022) Figure Europe H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table Europe H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) Table Europe H3N2 Infection Treatment Sales Market Share by Countries (2017-2022) Figure Europe H3N2 Infection Treatment Sales Market Share by Countries in 2021 Table Europe H3N2 Infection Treatment Revenue by Countries (2017-2022) Table Europe H3N2 Infection Treatment Revenue Market Share by Countries (2017-2022) Figure Europe H3N2 Infection Treatment Revenue Market Share by Countries in 2021 Figure Germany H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure UK H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure France H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Russia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Italy H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Spain H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Table Europe H3N2 Infection Treatment Revenue by Manufacturer (2021) Figure Europe H3N2 Infection Treatment Revenue Market Share by Manufacturer in 2021 Table Europe H3N2 Infection Treatment Sales by Type (2017-2022) Table Europe H3N2 Infection Treatment Sales Share by Type (2017-2022) Table Europe H3N2 Infection Treatment Sales by Application (2017-2022) Table Europe H3N2 Infection Treatment Sales Share by Application (2017-2022) Figure Asia-pacific H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table Asia-pacific H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) Table Asia-pacific H3N2 Infection Treatment Sales Market Share by Countries (2017-2022) Figure Asia-pacific H3N2 Infection Treatment Sales Market Share by Countries in 2021 Table Asia-pacific H3N2 Infection Treatment Revenue by Countries (2017-2022) Table Asia-pacific H3N2 Infection Treatment Revenue Market Share by Countries (2017-2022) Figure Asia-pacific H3N2 Infection Treatment Revenue Market Share by Countries in 2021 Figure China H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure South Korea H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Japan H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Australia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure India H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Southeast Asia H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Table Asia-pacific H3N2 Infection Treatment Revenue by Manufacturer (2021) Figure Asia-pacific H3N2 Infection Treatment Revenue Market Share by Manufacturer in 2021 Table Asia-pacific H3N2 Infection Treatment Sales by Type (2017-2022) Table Asia-pacific H3N2 Infection Treatment Sales Share by Type (2017-2022) Table Asia-pacific H3N2 Infection Treatment Sales by Application (2017-2022) Table Asia-pacific H3N2 Infection Treatment Sales Share by Application (2017-2022) Figure South America H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table South America H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) Table South America H3N2 Infection Treatment Sales Market Share by Countries (2017-2022) Figure South America H3N2 Infection Treatment Sales Market Share by Countries in 2019 Table South America H3N2 Infection Treatment Revenue by Countries (2017-2022) Table South America H3N2 Infection Treatment Revenue Market Share by Countries (2017-2022) Figure South America H3N2 Infection Treatment Revenue Market Share by Countries in 2019 Figure Brazil H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Table South America H3N2 Infection Treatment Sales by Type (2017-2022) Table South America H3N2 Infection Treatment Sales Share by Type (2017-2022) Table South America H3N2 Infection Treatment Revenue by Type (2017-2022) Table South America H3N2 Infection Treatment Revenue Share by Type (2017-2022) Table South America H3N2 Infection Treatment Sales by Application (2017-2022) Table South America H3N2 Infection Treatment Sales Share by Application (2017-2022) Figure Middle East and Africa H3N2 Infection Treatment Revenue and Growth Rate (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales (Volume) by Countries (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales Market Share by Countries (2017-2022) Figure Middle East and Africa H3N2 Infection Treatment Sales Market Share by Countries in 2019 Table Middle East and Africa H3N2 Infection Treatment Revenue by Countries (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Revenue Market Share by Countries (2017-2022) Figure Middle East and Africa H3N2 Infection Treatment Revenue Market Share by Countries in 2019 Figure GCC Countries H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Turkey H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure Egypt H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Figure South Africa H3N2 Infection Treatment Sales and Growth Rate (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales by Type (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales Share by Type (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Revenue by Type (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Revenue Share by Type (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales by Application (2017-2022) Table Middle East and Africa H3N2 Infection Treatment Sales Share by Application (2017-2022) Table Global H3N2 Infection Treatment Sales by Type (2017-2022) Table Global H3N2 Infection Treatment Sales Market Share by Type (2017-2022) Figure Global H3N2 Infection Treatment Sales Market Share by Type in 2021 Table Global H3N2 Infection Treatment Revenue by Type (2017-2022) Table Global H3N2 Infection Treatment Revenue Market Share by Type (2017-2022) Figure Global H3N2 Infection Treatment Revenue Market Share by Type in 2019 Figure Global APP-309 Sales Growth Rate (2017-2022) Figure Global APP-309 Price (2017-2022) Figure Global Aspidasept Sales Growth Rate (2017-2022) Figure Global Aspidasept Price (2017-2022) Figure Global C-05 Sales Growth Rate (2017-2022) Figure Global C-05 Price (2017-2022) Figure Global CR-8020 Sales Growth Rate (2017-2022) Figure Global CR-8020 Price (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Figure Global Others Price (2017-2022) Table Global H3N2 Infection Treatment Sales by Application (2017-2022) Table Global H3N2 Infection Treatment Sales Market Share by Application (2017-2022) Figure Global H3N2 Infection Treatment Sales Market Share by Application in 2021 Figure Global Clinic Sales Growth Rate (2017-2022) Figure Global Hospital Sales Growth Rate (2017-2022) Figure Global Others Sales Growth Rate (2017-2022) Figure Global H3N2 Infection Treatment Sales and Growth Rate (2022-2027) Figure Global H3N2 Infection Treatment Revenue and Growth Rate (2022-2027) Table Global H3N2 Infection Treatment Sales Forecast by Regions (2017-2022) Table Global H3N2 Infection Treatment Market Share Forecast by Regions (2017-2022) Figure North America Sales H3N2 Infection Treatment Market Forecast (2022-2027) Figure Europe Sales H3N2 Infection Treatment Market Forecast (2022-2027) Figure Asia-Pacific Sales H3N2 Infection Treatment Market Forecast (2022-2027) Figure South America Sales H3N2 Infection Treatment Market Forecast (2022-2027) Figure Middle East & Africa Sales H3N2 Infection Treatment Market Forecast (2022-2027) Table Global H3N2 Infection Treatment Sales Forecast by Type (2022-2027) Table Global H3N2 Infection Treatment Market Share Forecast by Type (2022-2027) Table Global H3N2 Infection Treatment Sales Forecast by Application (2022-2027) Table Global H3N2 Infection Treatment Market Share Forecast by Application (2022-2027) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table Macro Analysis of Upstream Markets Table Key Players in Upstream Markets Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of H3N2 Infection Treatment Table Macro Analysis of Down Markets Table Key Players in Down Markets Table Key Players of Downstream Markets Figure Sales Channel Figure Author List

AIMM Therapeutics B.V. Johnson & Johnson CSL Limited Aphios Corporation Inovio Pharmaceuticals, Inc. Crucell N.V. MedImmune, LLC ILiAD Biotechnologies, LLC Glide Pharmaceutical Technologies Limited Medicago Inc. Sarepta Therapeutics, Inc. Zydus Cadila Healthcare Limited Mucosis B.V. Takeda Pharmaceutical Company Limited OPKO Health, Inc. NanoViricides, Inc. Visterra, Inc. Novavax, Inc.